Making It Happen
Hong Kong Viral Hepatitis Action Plan 2020 – 2024 sets out its vision and outlines the specific actions for DH, HA and other stakeholders, as well as the time frames for implementation of the actions. Different targets are set under all priority areas to drive progress. Indicators for measuring the progress towards achievement of the targets are also included.
The progress of the elimination of HBV and HCV infection and gaps in implementing practice improvement strategies will be regularly monitored and reviewed for reaching the WHO 2030 targets.
Success in implementation can only be achieved with the efforts from all stakeholders in various sectors. The development of this Action Plan has highlighted the significant collegiality and commitment of different stakeholders.
| 2020 |
2021 |
2022 |
2023 |
2024 |
- 2020 theme: Chronic HBV and HCV infections are asymptomatic but cause liver cancer
- Enhanced awareness campaign
- Education materials for pregnant women
- KAP assessment for O&G staff
|
- 2021 theme: Prevention of vertical transmission of HBV
- KAP assessment of other healthcare workers
|
- 2022 theme: HBV – get tested and treated
- Develop education materials about HCV infection for PWID service providers
- Establish the yearly theme of awareness campaign 2023 - 2024
|
|
Review
and
Plan Ahead |
- Develop a set of local indicators
|
|
- Update value of Local Indicators of 2020
- Update HBV and HCV situation according to PHS
|
|
- Pilot MTCT prevention programme (use of antivirals)
- Establish the plan and resources for PVST
- Establish nurse clinics, beginning with QMH and PWH
- Use antivirals to prevent MTCT in all HA birthing hospitals
|
- Professional training to O&G staff
- Establish logistics and workflow of PVST
- Scale up nurse clinics
|
- Review the acceptance of using antivirals to prevent MTCT
- Implementation of PVST
|
- Review the acceptance of PVST
|
- DAA extended for patients with fibrosis stage F2 or above in 2019
- HCV micro-elimination in renal dialysis patients and HIV-positive patients
|
- Extend DAA for all hepatitis C patients
- Complete HCV micro-elimination in renal dialysis patients
|
- Review the service provided by nurse clinics
- Complete HCV micro-elimination in HIV-positive patients
|
- Develop and promulgate information resources to facilitate management of HBV infection by primary care
- Review the number of patients treated with DAA
|
| Enhance diagnosis and treatment capacity |
Highlight of key actions for 2020 - 2024